96 related articles for article (PubMed ID: 3001778)
1. Double-blind trial of suloctidil versus placebo in moderate to severe mental deterioration.
Baro F; Malfroid M; Waegemans T; Cox JP
Pharmatherapeutica; 1985; 4(6):399-404. PubMed ID: 3001778
[TBL] [Abstract][Full Text] [Related]
2. [The effect of Ginkgo biloba extract on neurophysiological and psychometric measurement results in patients with psychotic organic brain syndrome. A double-blind study against placebo].
Hofferberth B
Arzneimittelforschung; 1989 Aug; 39(8):918-22. PubMed ID: 2684175
[TBL] [Abstract][Full Text] [Related]
3. [Controlled study of the effect of dihydroergocristine on organic brain psychosyndrome].
Aranda B; Dumoulin P; Groothold G
Arzneimittelforschung; 1992 Nov; 42(11A):1406-9. PubMed ID: 1492863
[TBL] [Abstract][Full Text] [Related]
4. On the effects of pyritinol on functional deficits of patients with organic mental disorders.
Herrmann WM; Kern U; Röhmel J
Pharmacopsychiatry; 1986 Sep; 19(5):378-85. PubMed ID: 3534901
[TBL] [Abstract][Full Text] [Related]
5. Intermittent claudication: Suloctidil v.s. placebo treatment.
Holm J; Lindblad L; Scherstén T; Suurkula M
Vasa; 1984; 13(2):175-8. PubMed ID: 6331019
[No Abstract] [Full Text] [Related]
6. Nylidrin HCL in the treatment of symptoms of the aged: a double-blind placebo controlled study.
Goldstein SE; Birnbom F
J Clin Psychiatry; 1979 Dec; 40(12):520-4. PubMed ID: 500575
[TBL] [Abstract][Full Text] [Related]
7. Hypocholesterolaemic activity of suloctidil: double-blind, crossover short-term and long-term treatment trial.
Chieffo C; Postiglione A; Tritto C; Mancini M
Curr Med Res Opin; 1984; 9(3):147-52. PubMed ID: 6094103
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biological activity of the antiplatelet agent suloctidil in treatment of idiopathic recurrent vein thrombosis (I.R.V.T.).
Moriau M; Col-De Beys C; Pardonge E; Ferrant A
Thromb Haemost; 1982 Feb; 47(1):27-31. PubMed ID: 6280332
[TBL] [Abstract][Full Text] [Related]
9. [Trial of a new drug in Raynaud's disease. Clinical and thermographic control].
Dumoulin J
Electrodiagn Ther; 1981; 18(4):168-74. PubMed ID: 6279383
[No Abstract] [Full Text] [Related]
10. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
11. Controlled trial of suloctidil in intermittent claudication.
Verhaeghe R; Van Hoof A; Beyens G
J Cardiovasc Pharmacol; 1981; 3(2):279-86. PubMed ID: 6166799
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and instrumental evaluation of patients with chronic peripheral arterial occlusive disease after prolonged administration of suloctidil].
Gregoratti L; Redaelli G; Limido P; Ghiringhelli L
Clin Ter; 1982 Sep; 102(6):607-19. PubMed ID: 6291844
[No Abstract] [Full Text] [Related]
13. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
Spinella G; Majorana M
Clin Ter; 1983 Mar; 104(5):375-81. PubMed ID: 6303677
[No Abstract] [Full Text] [Related]
14. [Therapeutic use of a new vasoactive drug in cerebral vascular diseases in elderly patients].
Petronio G; Scali G; Casa B; Nonis E
Clin Ter; 1980 Aug; 94(4):427-44. PubMed ID: 6257445
[No Abstract] [Full Text] [Related]
15. Combination of suloctidil and anticoagulation in the prevention of reocclusion after femoro-popliteal PTA.
Mahler F; Schneider E; Gallino A; Bollinger A
Vasa; 1987; 16(4):381-5. PubMed ID: 2827398
[No Abstract] [Full Text] [Related]
16. [Dihydroergocristine in organic brain psychosyndrome. Multicenter placebo-controlled clinical double-blind study in 240 patients].
Lazzaroni M; Cattalini C; Massetto N; Poli A
Arzneimittelforschung; 1992 Nov; 42(11A):1410-3. PubMed ID: 1492864
[TBL] [Abstract][Full Text] [Related]
17. Suloctidil: long-term trial in the aged. Study of microcirculation, viscosity, red cell deformability, fibrinolysis and lipid fractions.
Merchan R; Zurita IE; Martinez JF
Arzneimittelforschung; 1985; 35(5):855-7. PubMed ID: 2992530
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term treatment with suloctidil on blood viscosity, erythrocyte deformability and total fibrinogen plasma levels in diabetic patients.
Roncucci R; De Hertogh R; Dormandy JA; Doumont J; Gurewich V; Lambelin G; Lansen J; Rottiers R; Souridis E; Van Stalle F; Versee L
Arzneimittelforschung; 1979; 29(4):682-4. PubMed ID: 582768
[TBL] [Abstract][Full Text] [Related]
19. A double-blind trial of suloctidil v. placebo in intermittent claudication.
Jones NA; De Haas H; Zahavi J; Kakkar VV
Br J Surg; 1982 Jan; 69(1):38-40. PubMed ID: 6274471
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of disorders of cerebral performance in the aged in ambulatory care using bencyclane. Results of a controlled double-blind phase III study versus placebo].
Garweg G; Herrmann WM; Kern U
Z Gerontol; 1987; 20(1):56-62. PubMed ID: 3554804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
